Tapewire

NYSE · USD

IQV

IQVIA HOLDINGS INC.

Export transactions ↓
Tapewire entity
3058
SEC CIK
0001478242
Parsed reports
432

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202607
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 28, 2022 Filed Feb 9, 2023 22:18 UTC GrantDeferred Shares · Derivative 127 $236.01 $29,973.27
Disclosure

SEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 3

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 870

Underlying: Common Stock · 127 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 28, 2022 Filed Feb 9, 2023 22:20 UTC GrantDeferred Shares · Derivative 133 $236.01 $31,389.33
Disclosure

SEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 3

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,494

Underlying: Common Stock · 133 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
July 28, 2022 Filed Feb 9, 2023 22:21 UTC GrantDeferred Shares · Derivative 116 $236.01 $27,377.16
Disclosure

SEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 3

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351

Underlying: Common Stock · 116 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:04 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000074 · wf-form4_165247573956603.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 25,339

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:03 UTC
Burt CarolDirector
GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000073 · wf-form4_165247567810499.xml · nonDerivative · entry 1

Burt Carol · CIK 0001493926 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 4,899

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:14 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000078 · wf-form4_165247635478900.xml · nonDerivative · entry 1

Stamps Sheila A · CIK 0001600782 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 995

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:05 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000076 · wf-form4_165247581647760.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,533

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:06 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000077 · wf-form4_165247585020750.xml · nonDerivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,180

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:05 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000075 · wf-form4_165247576743276.xml · nonDerivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 995

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
May 11, 2022 Filed May 13, 2022 21:02 UTC GrantCommon Stock 995 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000072 · wf-form4_165247564402913.xml · nonDerivative · entry 1

LEONARD JOHN M · CIK 0001563584 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,673

F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Read SEC document
May 11, 2022 Filed Feb 9, 2023 22:18 UTC GrantDeferred Shares · Derivative 136 $200.96 $27,330.56
Disclosure

SEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 2

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 743

Underlying: Common Stock · 136 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 11, 2022 Filed Feb 9, 2023 22:20 UTC GrantDeferred Shares · Derivative 143 $200.96 $28,737.28
Disclosure

SEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 2

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,361

Underlying: Common Stock · 143 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
May 11, 2022 Filed Feb 9, 2023 22:21 UTC GrantDeferred Shares · Derivative 131 $200.96 $26,325.76
Disclosure

SEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 2

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235

Underlying: Common Stock · 131 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:09 UTC
STAUB W RICHARDSee Remarks
GrantStock Appreciation Right · Derivative 5,462 $0.00 Strike: $250.43 $0.00
Disclosure

SEC source: 0001478242-22-000027 · wf-form4_164487653764987.xml · derivative · entry 2

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,462

Underlying: Common Stock · 5,462 shares

Expires 2032-02-10

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:09 UTC
STAUB W RICHARDSee Remarks
GrantCommon Stock 1,467 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000027 · wf-form4_164487653764987.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,841

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:08 UTC
Knightly Kevin CSee Remarks
GrantStock Appreciation Right · Derivative 7,283 $0.00 Strike: $250.43 $0.00
Disclosure

SEC source: 0001478242-22-000025 · wf-form4_164487646970481.xml · derivative · entry 2

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,283

Underlying: Common Stock · 7,283 shares

Expires 2032-02-10

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:08 UTC
Knightly Kevin CSee Remarks
GrantCommon Stock 1,956 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000025 · wf-form4_164487646970481.xml · nonDerivative · entry 1

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,115

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:08 UTC
Sherbet EricSee Remarks
GrantStock Appreciation Right · Derivative 8,193 $0.00 Strike: $250.43 $0.00
Disclosure

SEC source: 0001478242-22-000026 · wf-form4_164487650328594.xml · derivative · entry 2

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,193

Underlying: Common Stock · 8,193 shares

Expires 2032-02-10

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:08 UTC
Sherbet EricSee Remarks
GrantCommon Stock 2,200 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000026 · wf-form4_164487650328594.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,218

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:07 UTC
BOUSBIB ARIDirector · See Remarks
GrantStock Appreciation Right · Derivative 76,472 $0.00 Strike: $250.43 $0.00
Disclosure

SEC source: 0001478242-22-000023 · wf-form4_164487640620414.xml · derivative · entry 3

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,472

Underlying: Common Stock · 76,472 shares

Expires 2032-02-10

F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:07 UTC
BOUSBIB ARIDirector · See Remarks
GrantCommon Stock 20,542 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000023 · wf-form4_164487640620414.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 713,740

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:07 UTC GrantStock Appreciation Right · Derivative 2,184 $0.00 Strike: $250.43 $0.00
Disclosure

SEC source: 0001478242-22-000024 · wf-form4_164487643728959.xml · derivative · entry 2

Korakis Emmanuel N · CIK 0001449366 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,184

Underlying: Common Stock · 2,184 shares

Expires 2032-02-10

F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:07 UTC GrantCommon Stock 586 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000024 · wf-form4_164487643728959.xml · nonDerivative · entry 1

Korakis Emmanuel N · CIK 0001449366 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,932

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:06 UTC GrantStock Appreciation Right · Derivative 21,849 $0.00 Strike: $250.43 $0.00
Disclosure

SEC source: 0001478242-22-000022 · wf-form4_164487637172562.xml · derivative · entry 4

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,849

Underlying: Common Stock · 21,849 shares

Expires 2032-02-10

F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 22:06 UTC GrantCommon Stock 5,869 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000022 · wf-form4_164487637172562.xml · nonDerivative · entry 2

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,224

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023.

Read SEC document
February 10, 2022 Filed Feb 9, 2023 22:18 UTC GrantDeferred Shares · Derivative 110 $250.43 $27,547.30
Disclosure

SEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 607

Underlying: Common Stock · 110 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 10, 2022 Filed Feb 9, 2023 22:20 UTC GrantDeferred Shares · Derivative 114 $250.43 $28,549.02
Disclosure

SEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 1

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,218

Underlying: Common Stock · 114 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 10, 2022 Filed Feb 9, 2023 22:21 UTC GrantDeferred Shares · Derivative 104 $250.43 $26,044.72
Disclosure

SEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 1

Wims Morris Leslie · CIK 0001908079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104

Underlying: Common Stock · 104 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:07 UTC
STAUB W RICHARDSee Remarks
Tax withholdingCommon Stock 3,834 $255.57 $979,855.38
Disclosure

SEC source: 0001478242-22-000019 · wf-form4_164461722537812.xml · nonDerivative · entry 2

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,374

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:07 UTC
STAUB W RICHARDSee Remarks
GrantCommon Stock 9,114 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000019 · wf-form4_164461722537812.xml · nonDerivative · entry 1

STAUB W RICHARD · CIK 0001181162 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,208

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:08 UTC Tax withholdingCommon Stock 705 $255.57 $180,176.85
Disclosure

SEC source: 0001478242-22-000020 · wf-form4_164461729807520.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,342

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:06 UTC
BOUSBIB ARIDirector · See Remarks
Tax withholdingCommon Stock 50,039 $255.57 $12,788,467.23
Disclosure

SEC source: 0001478242-22-000018 · wf-form4_164461717832344.xml · nonDerivative · entry 2

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 693,198

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:06 UTC
BOUSBIB ARIDirector · See Remarks
GrantCommon Stock 91,142 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000018 · wf-form4_164461717832344.xml · nonDerivative · entry 1

BOUSBIB ARI · CIK 0001184180 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 743,237

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:05 UTC Tax withholdingCommon Stock 758 $255.57 $193,722.06
Disclosure

SEC source: 0001478242-22-000017 · wf-form4_164461712356816.xml · nonDerivative · entry 2

Korakis Emmanuel N · CIK 0001449366 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,346

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:05 UTC GrantCommon Stock 1,822 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000017 · wf-form4_164461712356816.xml · nonDerivative · entry 1

Korakis Emmanuel N · CIK 0001449366 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,104

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:04 UTC
Knightly Kevin CSee Remarks
Tax withholdingCommon Stock 3,961 $255.57 $1,012,312.77
Disclosure

SEC source: 0001478242-22-000016 · wf-form4_164461707663923.xml · nonDerivative · entry 2

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,159

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:04 UTC
Knightly Kevin CSee Remarks
GrantCommon Stock 9,114 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000016 · wf-form4_164461707663923.xml · nonDerivative · entry 1

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,120

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:04 UTC
Sherbet EricSee Remarks
Tax withholdingCommon Stock 3,788 $255.57 $968,099.16
Disclosure

SEC source: 0001478242-22-000015 · wf-form4_164461703666535.xml · nonDerivative · entry 2

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,018

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:04 UTC
Sherbet EricSee Remarks
GrantCommon Stock 9,114 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000015 · wf-form4_164461703666535.xml · nonDerivative · entry 1

Sherbet Eric · CIK 0001679512 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,806

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2019. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2022.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 22:14 UTC PurchaseCommon Stock 10,000 $272.93 $2,729,300.00
Disclosure

SEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · nonDerivative · entry 2

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 24,344

F3 · price: The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $270.67 to $274.52 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust.

Read SEC document
December 20, 2021 Filed Dec 23, 2021 22:14 UTC GiftCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · nonDerivative · entry 1

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 14,344

F1 · price: 20,000 shares were donated to the Danhakl Family Foundation for no remuneration.

F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust.

Read SEC document
December 03, 2021 Filed Feb 2, 2022 22:02 UTC GiftCommon Stock 290 $0.00 $0.00
Disclosure

SEC source: 0001478242-22-000006 · wf-form5_164383930182791.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,538

Read SEC document
December 02, 2021 Filed Dec 3, 2021 22:47 UTC GiftCommon Stock 7,865 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-046835 · doc4.xml · nonDerivative · entry 2

CONNAUGHTON JOHN · CIK 0001213395 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
December 02, 2021 Filed Dec 3, 2021 22:47 UTC OtherCommon Stock 62,390 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-046835 · doc4.xml · nonDerivative · entry 1

CONNAUGHTON JOHN · CIK 0001213395 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

F3 · kind: On December 2, 2021, Integral 2008 distributed 62,390 shares of common stock to its partners, including 7,865 shares of common stock to Mr. Connaughton, in connection with certain charitable gifts made by such partners.

F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008").

F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the general partner of Integral 2008. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to the shares of common stock held by Integral 2008. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
November 29, 2021 Filed Dec 1, 2021 23:02 UTC SaleCommon Stock 555,094 $262.60 $145,767,684.40
Disclosure

SEC source: 0000899243-21-046434 · doc4.xml · nonDerivative · entry 1

CONNAUGHTON JOHN · CIK 0001213395 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 62,390

F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"), BCIP TCV, LLC ("BCIP TCV") and BCIP Associates-G ("BCIP-G" and, collectively, the "Bain Capital Entities").

F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the general partner of Integral 2008 and governs the investment strategy and decision-making process with respect to investments held by each of BCIP TCV and BCIP-G. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of common stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
October 26, 2021 Filed Dec 23, 2021 22:14 UTC GrantDeferred Shares · Derivative 108 $256.09 $27,657.72
Disclosure

SEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · derivative · entry 6

DANHAKL JOHN G · CIK 0001162644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497

Underlying: Common Stock · 108 shares

Expires not disclosed

F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
October 26, 2021 Filed Feb 2, 2022 22:01 UTC GrantDeferred Shares · Derivative 113 $256.09 $28,938.17
Disclosure

SEC source: 0001478242-22-000005 · wf-form5_164383923231572.xml · derivative · entry 4

GOGGINS COLLEEN A · CIK 0001189008 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,104

Underlying: Common Stock · 113 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.

Read SEC document
October 25, 2021 Filed Feb 17, 2022 22:03 UTC SaleCommon Stock 4 $256.93 $1,027.72
Disclosure

SEC source: 0001478242-22-000043 · wf-form4_164513535199187.xml · nonDerivative · entry 2

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,224

F1 · acquired: The purchase and sale transactions were made without Mr. Bruehlman's knowledge by an independent financial broker/advisor who manages an investment account on Mr. Bruehlman's behalf.

Read SEC document
September 23, 2021 Filed Feb 17, 2022 22:03 UTC PurchaseCommon Stock 4 $262.82 $1,051.28
Disclosure

SEC source: 0001478242-22-000043 · wf-form4_164513535199187.xml · nonDerivative · entry 1

Bruehlman Ronald E · CIK 0001604076 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,228

F1 · acquired: The purchase and sale transactions were made without Mr. Bruehlman's knowledge by an independent financial broker/advisor who manages an investment account on Mr. Bruehlman's behalf.

Read SEC document
August 16, 2021 Filed Aug 18, 2021 21:00 UTC
Knightly Kevin CSee Remarks
SaleCommon Stock 6,055 $250.00 $1,513,750.00
Disclosure

SEC source: 0001478242-21-000055 · wf-form4_162932042335219.xml · nonDerivative · entry 1

Knightly Kevin C · CIK 0001350000 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,006

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.